top of page
Drug Development in NMIBC from Scientific, Regulatory, Clinician, and Patient Perspectives (2021)
AUA
3/4/21, 6:00 PM
America/New York GMT -4 summer
Description
Previous registration necessary?
NO
YES
Simultaneous translation ?
NO
YES
Will it be recorded?
NO
YES
Yair Lotan, John Sfakianos
Welcome, Opening Remarks, Bladder Cancer Advocacy Network (BCAN) Patient Panel, PANEL: Clinical Development of Therapies for NMIBC: What is Success?, Discussion, Q&A, SESSION ONE: Drug Development for BCG-Naïve NMIBC, Model Systems to Facilitate Development of Therapies for NMIBC, What Novel Therapies Can Compete (or Combine) with BCG in BCG-Naïve NMIBC?, Regulatory Considerations in the BCG-Naïve NMIBC Setting, Discussion, Q&A
Inglês
Description
Speakers
Matthew Galsky, Yair Lotan, David McConkey, Aria F. Olumi, Carolyn J.M. Best, Seth Lerner, Noah Hahn, Brian Baumann, Elaine Chang, Phillip Abbosh, Robert Svatek, Chana Weinstock
Speakers
Link to the Event
Banner to the Event
Link to Event
Banner
Register your event here
Already have an account? LOGIN HERE. If You don't have an account you need to create a free account.
Registro
bottom of page